Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

3
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
3
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

165
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
165
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

2
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
2
Vaccinations01:51

Vaccinations

54.7K
Overview
54.7K
Vaccines01:21

Vaccines

63
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
63
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

66
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and severity of pediatric influenza hospitalizations before and during the COVID-19 pandemic: a surveillance study of the Canadian immunization monitoring program (IMPACT), 2012-2023.

Lancet regional health. Americas·2026
Same author

mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network.

Vaccine·2026
Same author

Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network.

Human vaccines & immunotherapeutics·2026
Same author

Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network.

Human vaccines & immunotherapeutics·2026
Same author

Changes in hospital admissions associated with pediatric respiratory syncytial virus after the COVID-19 pandemic in Canada: an active surveillance study.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Association of perinatal care provider type with routine vaccination in first two years of life in British Columbia, Canada.

Vaccine·2026
Same journal

Projected health and economic impact of PCV20 vaccination in UK children: a dynamic transmission model.

Expert review of vaccines·2026
Same journal

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026
Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026
Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Evolving meningococcal immunization strategies.

Marco Aurélio Sáfadi1, Julie A Bettinger, Gabriela Moreno Maturana

  • 1FCM da Santa Casa de São Paulo, São Paulo, Brazil.

Expert Review of Vaccines
|December 11, 2014
PubMed
Summary
This summary is machine-generated.

Meningococcal conjugate vaccines, targeting adolescents and specific serogroups, have dramatically reduced disease incidence. Enhanced surveillance is crucial for optimizing future immunization policies against meningococcal disease.

Keywords:
Neisseria meningitidisconjugate vaccineimmunization schedulemeningococcalserogroup Aserogroup Cserogroup W

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K

Area of Science:

  • Public Health
  • Epidemiology
  • Immunology

Background:

  • Meningococcal disease poses a significant global health threat.
  • Immunization is the primary prevention strategy.
  • Serogroup C conjugate vaccines have shown high effectiveness in adolescents.

Purpose of the Study:

  • To evaluate the impact of meningococcal conjugate vaccines.
  • To highlight the effectiveness of adolescent and mass immunization programs.
  • To emphasize the need for ongoing surveillance in response to new vaccination strategies.

Main Methods:

  • Review of immunization schedules and catch-up programs in various countries.
  • Analysis of disease incidence reduction post-vaccination.
  • Monitoring of vaccine use in adolescent and epidemic control programs.

Main Results:

  • Significant reduction in serogroup C meningococcal disease incidence in vaccinated and unvaccinated populations.
  • Successful implementation of quadrivalent meningococcal vaccines in North America and South America.
  • Control of serogroup A meningococcal disease epidemics in the African meningitis belt through mass immunization.

Conclusions:

  • Meningococcal conjugate vaccines are highly effective in controlling disease.
  • Targeted adolescent immunization and mass campaigns are successful strategies.
  • Enhanced epidemiological surveillance is essential for refining immunization policies.